Franklin Mining, Inc. (FMNJ)

[t h i n k f i s h]

The Rothschild family wishes to do its part with BMGP why not with FMNJ?

Biomagnetics Diagnostics Corp. Appoints Charles Gregoire de Rothschild Special
Adviser to Board

Biomagnetics Diagnostics Corp. (Pink Sheets:BMGP), a producer of revolutionary diagnostic systems and technology for malaria, tuberculosis, HIV and hepatitis testing today announced the appointment of international financier Charles Gregoire de Rothschild to the role of special adviser to the Company's board of directors. Mr. de Rothschild will support Biomagnetics’ continuing global expansion efforts by leveraging his extensive domestic and international financial expertise.
“Western countries are finally waking up to the ongoing malaria crisis, which claims more than one million lives each year. While there have been some notable gains in malaria prevention over the past few years, the area of malaria testing and diagnostics has progressed very slowly. The world is in desperate need of low-cost, field deployable tools to diagnose malaria,” said Mr. de Rothschild.
For nearly 100 years, the direct microscopic visualization of the malaria parasite on blood smears has been the accepted method of diagnostics of malaria in most settings. This process must usually be performed in a laboratory setting by trained personnel. While field deployable, non-microscopic tests have been introduced, the efficacy of these tests is often called into question.
Mr. de Rothschild continued, “The Rothschild family wishes to do its part to advance this area of research and will be providing its support to develop better diagnostic tools. We have reviewed the technology under development by Biomagnetics Diagnostics and believed it to be revolutionary, holding the potential to cut the cost of testing by nearly two thirds. Additionally, because the technology is handheld, portable and easy to use, testing can be conducted by relatively untrained medical personnel. We believe the development of this technology could potentially save tens of thousands of lives each year and we wish to help speed its entry to market.”
According to the World Health Organization, some 3.2 billion people, or about half the world's population is at risk of malaria transmission in 107 countries and territories worldwide. While there are between 350 million and 500 million new cases of malaria each year, there are very few reliable and field deployable diagnostic tools available. Early detection substantially improves treatability and survivability. Field deployable integrated optical biosensor systems, such as those under development at Biomagnetics Diagnostics, hold the promise to significantly speed the diagnostic testing process and to meaningfully lower costs.
About Biomagnetics Diagnostics Corp.
Biomagnetics Diagnostics Corporation is an advanced medical device and biotechnology company. The Company’s revolutionary diagnostic systems, which are based on advanced magnetics, test for any viral or bacterial disease using any body fluid. The Company's technology allows laboratories to perform far more tests in the same amount of time it takes to do a single test. The HTS-MTP platform is designed to detect the actual virus and viral load in body fluids and not just simply screen for the presence of viral antibodies. More information on Biomagnetics Diagnostics Corp. can be seen at www.BiomagneticsBMGP.com

http://www.euroinvestor.co.uk/news/story.aspx?id=10662362&bw=20091008005367

PEACE